225 related articles for article (PubMed ID: 9494572)
21. Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract.
Freudenstein J; Dasenbrock C; Nisslein T
Cancer Res; 2002 Jun; 62(12):3448-52. PubMed ID: 12067987
[TBL] [Abstract][Full Text] [Related]
22. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
[TBL] [Abstract][Full Text] [Related]
23. Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors.
De Coster R; Van Ginckel RF; Callens MJ; Goeminne NK; Janssens BL
Cancer Res; 1992 Mar; 52(5):1240-4. PubMed ID: 1737385
[TBL] [Abstract][Full Text] [Related]
24. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
25. Obesity increases the incidence of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in an ovariectomized Zucker rat model.
Hakkak R; MacLeod S; Shaaf S; Holley AW; Simpson P; Fuchs G; Jo CH; Kieber-Emmons T; Korourian S
Int J Oncol; 2007 Mar; 30(3):557-63. PubMed ID: 17273756
[TBL] [Abstract][Full Text] [Related]
26. Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer model.
Mafuvadze B; Cook M; Xu Z; Besch-Williford CL; Hyder SM
Nutr Cancer; 2013; 65(8):1184-91. PubMed ID: 24127693
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological actions of a novel, potent, tissue-selective benzopyran estrogen.
Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
J Pharmacol Exp Ther; 2002 Oct; 303(1):196-203. PubMed ID: 12235251
[TBL] [Abstract][Full Text] [Related]
28. Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.
Cook MT; Mafuvadze B; Besch-Williford C; Ellersieck MR; Goyette S; Hyder SM
Oncol Rep; 2016 Feb; 35(2):825-32. PubMed ID: 26719029
[TBL] [Abstract][Full Text] [Related]
29. Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue transgenic rats.
Manjanatha MG; Shelton S; Bishop ME; Lyn-Cook LE; Aidoo A
Carcinogenesis; 2006 Dec; 27(12):2555-64. PubMed ID: 17127718
[TBL] [Abstract][Full Text] [Related]
30. Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue transgenic rats.
Manjanatha M; Shelton S; Bishop M; Lyn-Cook L; Aidoo A
Carcinogenesis; 2006 Oct; 27(10):1970-9. PubMed ID: 16709578
[TBL] [Abstract][Full Text] [Related]
31. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
[TBL] [Abstract][Full Text] [Related]
32. Effect of estrone on the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in the rat: a model of postmenopausal breast cancer.
Li S; Martel C; Dauvois S; Bélanger A; Labrie F
Endocrinology; 1994 Mar; 134(3):1352-7. PubMed ID: 8119175
[TBL] [Abstract][Full Text] [Related]
33. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
[TBL] [Abstract][Full Text] [Related]
34. Dietary genistein increased DMBA-induced mammary adenocarcinoma in wild-type, but not ER alpha KO, mice.
Day JK; Besch-Williford C; McMann TR; Hufford MG; Lubahn DB; MacDonald RS
Nutr Cancer; 2001; 39(2):226-32. PubMed ID: 11759285
[TBL] [Abstract][Full Text] [Related]
35. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
[TBL] [Abstract][Full Text] [Related]
36. Effects of danazol on proliferation and viability of 7,12-dimethylbenz(a)anthracene-induced mammary tumours in rats.
Yoshimura S; Sakamoto S; Kudo H; Suzuki S; Sassa S; Matsubara M; Nagasawa H
Anticancer Res; 1995; 15(1):61-5. PubMed ID: 7733642
[TBL] [Abstract][Full Text] [Related]
37. Protective effects of progesterone and tamoxifen in estrogen-induced mammary carcinogenesis in ovariectomized W/Fu rats.
Inoh A; Kamiya K; Fujii Y; Yokoro K
Jpn J Cancer Res; 1985 Aug; 76(8):699-704. PubMed ID: 3930447
[TBL] [Abstract][Full Text] [Related]
38. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate.
Odmark IS; Jonsson B; Bäckström T
Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178
[TBL] [Abstract][Full Text] [Related]
39. Independent regulation of growth and steroid receptors in uterus and mammary tumors of rats.
Janssens JP; Billiet G; Bonte J; De Loecker W
Anticancer Res; 1983; 3(6):385-91. PubMed ID: 6230984
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of mammary gland tumors by short-term treatment of estradiol-3-benzoate associated with down-regulation of estrogen receptor ERalpha and ERbeta.
Kang JS; Kim S; Che JH; Nam KT; Kim DJ; Jang DD; Yang KH
Oncol Rep; 2004 Oct; 12(4):689-93. PubMed ID: 15375486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
